Peptidomimetics present organic molecules that mimic the action of peptides, which can resemble peptides structurally but differ significantly in their side chains or molecular backbone. An attractive approach to discovering modulators of protein-protein interactions is to use small molecule mimics of β-turn recognition motifs to mimic key interaction residues. The β-turn is one of the three major secondary structure motifs found in proteins and peptides, and occurs where the polypeptide chain reverses direction. In recent years, mimetics of β-turns have been extensively studied and used to discover compounds that can mimic or disrupt β-turn-mediated recognition events. Designing peptides to mimic the behavior of β-turn is easier because most of the designs are less prone to conformational changes than those for α-helix. Peptidomimetic must interact with proteins in a manner similar to natural ligands.
BOC Sciences has designed a β-turn motifs library by employing a variety of ideal β-turn mimetic scaffold.
Figure 1. β-Sheets with general stabilization and mimicking approaches. (Pelaygimeno, M.; et al. 2015)
BOC Sciences supports the following three approaches to design our library:
Figure 2. Scaffolds that mimic β-turn conformations. (Pelaygimeno, M.; et al. 2015)
Figure 3. β-Sheet mimetics: Turn mimetics: L-Pro-D-Pro. (Pelaygimeno, M.; et al. 2015)
BOC Sciences provides professional, rapid and high-quality services of β-Turn Mimetics Library design at competitive prices for global customers. Personalized and customized services of β-Turn Mimetics Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.